Literature DB >> 23381794

MicroRNAs involved in the regulation of postischemic cardiac fibrosis.

Yao Dai1, Magomed Khaidakov, Xianwei Wang, Zufeng Ding, Wei Su, Elvin Price, Philip Palade, Mingwei Chen, Jawahar L Mehta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23381794     DOI： 10.1161/HYPERTENSIONAHA.111.00654

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  13 in total

1.  A system view and analysis of essential hypertension.

Authors:  Alon Botzer; Ehud Grossman; John Moult; Ron Unger
Journal:  J Hypertens       Date:  2018-05       Impact factor: 4.844

2.  Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats.

Authors:  Jana P Ball; Maryam Syed; Rodrigo O Marañon; Michael E Hall; Roshan Kc; Jane F Reckelhoff; Licy L Yanes Cardozo; Damian G Romero
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

3.  MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction.

Authors:  Maryam Syed; Jana P Ball; Keisa W Mathis; Michael E Hall; Michael J Ryan; Marc E Rothenberg; Licy L Yanes Cardozo; Damian G Romero
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-28       Impact factor: 4.310

4.  MicroRNA-9 regulates cardiac fibrosis by targeting PDGFR-β in rats.

Authors:  Lei Wang; LiKun Ma; Hai Fan; Zhe Yang; LongWei Li; HanZhang Wang
Journal:  J Physiol Biochem       Date:  2016-02-19       Impact factor: 4.158

Review 5.  The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand?

Authors:  Wino J Wijnen; Yigal M Pinto; Esther E Creemers
Journal:  J Cardiovasc Transl Res       Date:  2013-07-03       Impact factor: 4.132

6.  MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1.

Authors:  Ranran Cheng; Ruiying Dang; Yan Zhou; Min Ding; Huikun Hua
Journal:  Hum Cell       Date:  2017-03-01       Impact factor: 4.174

Review 7.  Exercise training in hypertension: Role of microRNAs.

Authors:  Vander José das Neves; Tiago Fernandes; Fernanda Roberta Roque; Ursula Paula Renó Soci; Stéphano Freitas Soares Melo; Edilamar Menezes de Oliveira
Journal:  World J Cardiol       Date:  2014-08-26

8.  Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF β-Smad signal pathway.

Authors:  Yun Chen; Shengju Yang; Wenjuan Yao; Hongyan Zhu; Xiaole Xu; Guoliang Meng; Wei Zhang
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

9.  Cardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy.

Authors:  Wino J Wijnen; Ingeborg van der Made; Stephanie van den Oever; Monika Hiller; Bouke A de Boer; Daisy I Picavet; Iliana A Chatzispyrou; Riekelt H Houtkooper; Anke J Tijsen; Jaco Hagoort; Henk van Veen; Vincent Everts; Jan M Ruijter; Yigal M Pinto; Esther E Creemers
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

10.  miR-19b controls cardiac fibroblast proliferation and migration.

Authors:  Chongjun Zhong; Kun Wang; Ying Liu; Dongchao Lv; Bo Zheng; Qiulian Zhou; Qi Sun; Ping Chen; Shengguang Ding; Yiming Xu; Haitao Huang
Journal:  J Cell Mol Med       Date:  2016-04-06       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.